The term sarcopenia was first introduced in 1988 by Irwin Rosenberg to define a condition of
muscle loss that occurs in the elderly. Since then, a broader definition comprising not only …

Background Sarcopenic obesity is a clinical and functional condition characterized by the
coexistence of excess fat mass and sarcopenia. Currently, different definitions of sarcopenic …

Skeletal muscle mass and muscle function are negatively affected by a variety of conditions
inherent to chronic kidney disease (CKD) and to dialysis treatment. Skeletal muscle mass …

Dyslipidemia is a common nutritional and metabolic disorder in patients with chronic kidney
disease. Accumulating evidence supports the hypothesis that prolonged metabolic …

Introduction Sarcopenia is a chronic condition that is associated with aging and
characterized by a reduction of muscle mass, strength, and function. Sarcopenia is prevalent …

Sarcopenia, a condition characterized by loss of skeletal muscle mass and function, has
important clinical ramifications. We aimed to map the existing literature about prevalence …

Obesity predisposes for atrial fibrillation, heart failure, sudden cardiac death, renal disease
and ischemic stroke, which are the main causes of cardiovascular hospitalization and …

The clinical consequences of obesity on the kidneys, with or without metabolic
abnormalities, involve both renal function and structures. The mechanisms linking obesity …

Muscle wasting (or sarcopenia) is a common feature of the uremic phenotype and
predisposes this vulnerable patient population to increased risk of comorbid complications …

Background Sarcopenia and poor physical function are common in patients with chronic
kidney disease (CKD). Our aim was to investigate the relationships between muscle mass …